The most important human pathogen Streptococcus pyogenes shares an intimate evolutionary historical past with cellular genetic parts, which in lots of circumstances carry genes encoding bacterial virulence elements. Throughout current whole-genome sequencing of a longitudinal pattern of S. pyogenes isolates in England, we recognized a lineage inside emmemmemmemmS. pyogenes appeared to represent predominantly MEW427-like isolates, whereas the UK inhabitants comprised each MEW427-like and MGAS10750-like isolates.
The degraded and cryptic nature of those parts might have necessary phenotypic and health ramifications for emmS. pyogenes, and the geographical distribution of this lineage raises fascinating questions on the inhabitants dynamics of the genotype.
Sequential quadriplex real-time PCR for figuring out 20 frequent emm varieties of Group A Streptococcus
We developed a sequential quadriplex real-time PCR-based methodology for fast identification of 20 emm sorts generally present in invasive GAS (iGAS) strains recovered by means of the Facilities for Illness Management and Prevention’s Lively Bacterial Core surveillance.
Every emm real-time PCR assay exhibits excessive specificity and precisely recognized the respective goal emm kind, together with emm subtypes in the US. Moreover, this methodology is helpful for fast typing of GAS isolates and culture-negative specimens throughout outbreak investigations.
Development inhibition of pathogenic microorganisms by Pseudomonas protegens EMM-1 and partial characterization of inhibitory substances
The bacterial pressure, EMM-1, was remoted from the rhizosphere of purple maize (“Rojo Criollo”) and recognized as Pseudomonas protegens EMM-1 primarily based on phylogenetic evaluation of 16S rDNA, rpoB, rpoD, and gyrB gene sequences. We uncovered genes concerned within the manufacturing of antimicrobial compounds like 2,4-diacetylphloroglucinol (2,4-DAPG), pyoluteorin, and lectin-like bacteriocins.
These antimicrobial compounds are additionally produced by different fluorescent pseudomonads alike P. protegens. Double-layer agar assay confirmed that P. protegens EMM-1 inhibited the expansion of a number of multidrug-resistant (MDR) micro organism, particularly scientific isolates of the genera Klebsiella and β-hemolytic Streptococcus.
This pressure additionally displayed inhibitory results towards various fungi, resembling Aspergillus, Botrytis, and Fusarium. In addition to, a crude extract of inhibitory substances secreted into agar was obtained after the cold-leaching course of, and physicochemical characterization was carried out. The partially purified inhibitory substances produced by P. protegens EMM-1 inhibited the expansion of Streptococcus sp. and Microbacterium sp., however no inhibitory impact was famous for different bacterial or fungal strains.
The molecular weight decided after ultrafiltration was between Three and 10 kDa. The inhibitory exercise was thermally secure as much as 60°C (however utterly misplaced at 100°C), and the inhibitory exercise remained energetic in a large pH vary (from Three to 9). After therapy with a protease from Bacillus licheniformis, the inhibitory exercise was decreased by 90%, suggesting the presence of proteic pure compounds. All these findings prompt that P. protegens EMM-1 is a possible supply of antimicrobials for use towards pathogens for people and crops.
Systematic Evaluate and Meta-analysis of the Prevalence of Group A Streptococcal emm Clusters in Africa To Inform Vaccine Growth
An emm-cluster primarily based system was proposed as a regular typing scheme to facilitate and improve future research of group A Streptococcus (GAS) epidemiological surveillance, M protein operate, and vaccine improvement methods. We offer an evidence-based distribution of GAS emm clusters in Africa and assess the potential protection of the brand new 30-valent vaccine by way of an emm cluster-based method.
Two reviewers independently assessed research retrieved from a complete search and extracted related knowledge. Meta-analyses had been carried out (random-effects mannequin) to mixture emm cluster prevalence estimates. Eight research (n = 1,595 isolates) revealed the predominant emm clusters as E6 (18%; 95% confidence interval [CI], 12.6% to 24.0%), adopted by E3 (14%; 95% CI, 11.2% to 17.4%) and E4 (13%; 95% CI, 9.5% to 16.0%).
There was negligible variation in emm clusters with regard to areas, age, and socioeconomic standing throughout the continent. Contemplating an emm cluster-based vaccine technique, which assumes cross-protection inside clusters, the 30-valent vaccine presently in scientific improvement would supply hypothetical protection to 80.3% of isolates in Africa.
This systematic evaluation signifies essentially the most predominant GAS emm cluster in Africa is E6 adopted by E3, E4, and D4. The present 30-valent vaccine would supply appreciable protection throughout the range of emm cluster sorts in Africa. Future efforts could possibly be directed towards estimating the general potential protection of the brand new 30-valent vaccine primarily based on cross-opsonization research with consultant panels of GAS isolates from populations at highest danger for GAS ailments.
IMPORTANCE Low vaccine protection is of grave public well being concern, notably in growing nations the place epidemiological knowledge are sometimes absent. To tell vaccine improvement for group A Streptococcus (GAS), we report on the epidemiology of the M protein emm clusters from GAS infections in Africa, the place GAS-related sicknesses and their sequelae, together with rheumatic fever and rheumatic coronary heart illness, are of a excessive burden.
This primary report of emm clusters throughout the continent signifies a excessive in all probability of protection by the M protein-based vaccine presently present process testing had been an emm-cluster primarily based method for use.
emm Varieties and clusters and macrolide resistance of pediatric group A streptococcal isolates in Central Greece throughout 2011-2017.
The surveillance of emm sorts and macrolide susceptibility of group A streptococcus (GAS) in varied areas and time durations enhances the understanding of the epidemiology of GAS infections and should information therapy methods and the formulation of type-specific vaccines. Greece has emerged as a rustic with excessive macrolide use. Nonetheless, research counsel a gradual discount in macrolide consumption after 2007.
Throughout a 7-year interval (2011-2017), 604 GAS isolates had been recovered from consecutive kids presenting with pharyngeal or nonpharyngeal infections in Central Greece; 517 viable isolates underwent molecular evaluation, together with emm typing.Isolates belonged to 20 completely different emm sorts (in lowering order of prevalence: 1, 89, 4, 12, 28, 3, 75 and 6, accounting for 88.2% of complete isolates). The emm sorts comprised 10 emm clusters (5 commonest clusters: E4, A-C3, E1, A-C4 and A-C5). The emm89 isolates had been acapsular (‘new clade’).
Total macrolide resistance price was 15.4%, and cMLSB emerged because the predominant resistance phenotype (56.4%). The bottom annual resistance charges occurred in 2014 (13.1%), 2016 (5.5%) and 2017(8.0%) (P for development = 0.002). Consumption of macrolide/lincosamide/streptogramin B declined by 22.6% throughout 2011-2017.
Macrolide resistance and emm28 and emm77 sorts had been related (each P<0.001). Essentially the most steadily recognized genetic lineages of macrolide-resistant GAS included emm28/ST52, emm77/ST63, emm12/ST36, emm89/ST101 and emm4/ST39. We estimated that 98.8% of the isolates belonged to emm sorts integrated right into a novel 30-valent M protein vaccine.In Central Greece throughout 2011-2017, the acapsular emm89 isolates comprised the second most prevalent kind.
Mouse Monoclonal Anti-Human CD147-FITC conjugate |
|||
| CD147F-100 | Alpha Diagnostics | 100 Tests | 562.8 EUR |
Mouse Anti Human Cd147 Monoclonal Antibody,AZIDE FREE |
|||
| CABT-47078MH | Creative Diagnostics | 0.1 mg | 795.6 EUR |
Mouse CD147 ELISA Kit |
|||
| EMC0241 | Abclonal | 96Tests | 625.2 EUR |
anti- CD147 antibody |
|||
| FNab01430 | FN Test | 100µg | 606.3 EUR |
|
Description: Antibody raised against CD147 |
|||
Mouse Monoclonal Anti-Human CD147-PE-Cy5-conjugate |
|||
| CD147PC-100 | Alpha Diagnostics | 100 Tests | 562.8 EUR |
Mouse CD147/EMMPRIN ELISA Kit |
|||
| EME0043 | Abclonal | 96Tests | 625.2 EUR |
Mouse CD147/EMMPRIN ELISA kit |
|||
| E03C0234-192T | BlueGene | 192 tests | 1524 EUR |
|
Description: A competitive ELISA for quantitative measurement of Mouse CD147/EMMPRIN in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Mouse CD147/EMMPRIN ELISA kit |
|||
| E03C0234-48 | BlueGene | 1 plate of 48 wells | 624 EUR |
|
Description: A competitive ELISA for quantitative measurement of Mouse CD147/EMMPRIN in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Mouse CD147/EMMPRIN ELISA kit |
|||
| E03C0234-96 | BlueGene | 1 plate of 96 wells | 822 EUR |
|
Description: A competitive ELISA for quantitative measurement of Mouse CD147/EMMPRIN in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Anti-Hu CD147 PE |
|||
| 1P-274-T025 | ExBio | 25 tests | 168 EUR |
Anti-Hu CD147 PE |
|||
| 1P-274-T100 | ExBio | 100 tests | 288 EUR |
Anti-Hu CD147 APC |
|||
| 1A-274-T025 | ExBio | 25 tests | 168 EUR |
Anti-Hu CD147 APC |
|||
| 1A-274-T100 | ExBio | 100 tests | 288 EUR |
Anti-Hu CD147 FITC |
|||
| 1F-274-T025 | ExBio | 25 tests | 146.4 EUR |
Anti-Hu CD147 FITC |
|||
| 1F-274-T100 | ExBio | 100 tests | 244.8 EUR |
Anti-Hu CD147 Biotin |
|||
| 1B-274-C025 | ExBio | 0.025 mg | 146.4 EUR |
Anti-Hu CD147 Biotin |
|||
| 1B-274-C100 | ExBio | 0.1 mg | 244.8 EUR |
Anti-Hu CD147 Purified |
|||
| 11-274-C025 | ExBio | 0.025 mg | 124.8 EUR |
Anti-Hu CD147 Purified |
|||
| 11-274-C100 | ExBio | 0.1 mg | 200.4 EUR |
Anti-Hu CD147 Purified |
|||
| 11-454-C025 | ExBio | 0.025 mg | 124.8 EUR |
Anti-Hu CD147 Purified |
|||
| 11-454-C100 | ExBio | 0.1 mg | 200.4 EUR |
Anti-Hu CD147 Alexa Fluor488 |
|||
| A4-274-T025 | ExBio | 25 tests | 184.8 EUR |
Anti-Hu CD147 Alexa Fluor488 |
|||
| A4-274-T100 | ExBio | 100 tests | 322.8 EUR |
Recombinant Mouse Basigin/CD147 (C-6His) |
|||
| CP80-10ug | Novoprotein | 10ug | 169.2 EUR |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
|||
Recombinant Mouse Basigin/CD147 (C-6His) |
|||
| CP80-1mg | Novoprotein | 1mg | 2008.8 EUR |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
|||
Recombinant Mouse Basigin/CD147 (C-6His) |
|||
| CP80-500ug | Novoprotein | 500ug | 1423.2 EUR |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
|||
Recombinant Mouse Basigin/CD147 (C-6His) |
|||
| CP80-50ug | Novoprotein | 50ug | 363.6 EUR |
|
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
|||
CD147 antibody |
|||
| 10R-CD147aHU | Fitzgerald | 100 ug | 484.8 EUR |
|
Description: Mouse monoclonal CD147 antibody |
|||
CD147 Antibody |
|||
| AF0428 | Affbiotech | 200ul | 420 EUR |
CD147 Antibody |
|||
| AF5221 | Affbiotech | 200ul | 420 EUR |
CD147 Antibody |
|||
| 49372-100ul | SAB | 100ul | 399.6 EUR |
CD147 Antibody |
|||
| 49372-50ul | SAB | 50ul | 286.8 EUR |
CD147 antibody |
|||
| 70R-14065 | Fitzgerald | 100 ug | 386.4 EUR |
|
Description: Affinity purified Mouse polyclonal CD147 antibody |
|||
CD147 antibody |
|||
| 70R-31695 | Fitzgerald | 100 ug | 392.4 EUR |
|
Description: Rabbit polyclonal CD147 antibody |
|||
CD147 antibody |
|||
| 70R-51470 | Fitzgerald | 100 ul | 292.8 EUR |
|
Description: Purified Polyclonal CD147 antibody |
|||
CD147 Antibody |
|||
| ABD3164 | Lifescience Market | 100 ug | 525.6 EUR |
CD147 Antibody |
|||
| ABF0428 | Lifescience Market | 100 ug | 525.6 EUR |
CD147 Antibody |
|||
| ABF5221 | Lifescience Market | 100 ug | 525.6 EUR |
CD147 Antibody |
|||
| DF6462 | Affbiotech | 200ul | 420 EUR |
CD147 Antibody |
|||
| R30601 | NSJ Bioreagents | 100 ug | 356.15 EUR |
|
Description: Emmprin, extracellular matrix metalloproteinase inducer, also known as Emmprin(BSG) or cluster of differentiation 147 is a protein that in humans is encoded by the Emmprin gene. The gene contains 8 exons and spans 10.8 kb. This protein is a determinant for the Ok blood group system. CD147 has been shown to be an essential receptor on red blood cells for the malaria parasite. It is a member of the immunoglobulin superfamily, with a structure related to the putative primordial form of the family. As members of the immunoglobulin superfamily play fundamental roles in intercellular recognition involved in various immunologic phenomena, differentiation, and development, It is though also to play a role in intercellular recognition. CD147 also regulates several distinct functions, such as spermatogenesis, expression of the monocarboxylate transporter and the responsiveness of lymphocytes. It is a type I integral membrane receptor that has many ligands, including the cyclophilin(CyP) proteins Cyp-A and CyP-B and certain integrins. It is expressed by many cell types, including epithelial cells, endothelial cells and leukocytes. |
|||
CD147 Antibody |
|||
| R31660 | NSJ Bioreagents | 100 ug | 356.15 EUR |
|
Description: Cluster of differentiation 147 is a member of the immunoglobulin superfamily, with a structure related to the putative primordial form of the family. As members of the immunoglobulin superfamily, it plays fundamental roles in intercellular recognition involved in various immunologic phenomena, differentiation, and development. CD147 is thought also to play a role in intercellular recognition. It also regulates several distinct functions, such as spermatogenesis, expression of the monocarboxylate transporter and the responsiveness of lymphocytes. |
|||
CD147 |
|||
| 147A1-100T | ImmunoStep | 100 test | 418.8 EUR |
CD147 |
|||
| 147CFB1-100T | ImmunoStep | 100 test | 465.6 EUR |
CD147 |
|||
| 147F1-100T | ImmunoStep | 100 test | 356.4 EUR |
CD147 |
|||
| 147P1E-100T | ImmunoStep | 100 test | 418.8 EUR |
CD147 |
|||
| 147PE2-100T | ImmunoStep | 100 test | 418.8 EUR |
CD147 |
|||
| 147PP1-100T | ImmunoStep | 100 test | 418.8 EUR |
CD147 |
|||
| 147PU1-01MG | ImmunoStep | 0,1 mg | 262.8 EUR |
Recombinant Mouse CD147 Protein (aa 1-209) [Fc] |
|||
| VAng-Cr3911-100g | Creative Biolabs | 100 µg | 2024.4 EUR |
|
Description: Recombinant Mouse CD147 Protein (Met 1-Arg 209) fused with a Fc tag at C-terminus was expressed in HEK293 Cells, with a molecular weight of 48.6 kDa. (Accession ID: NP_001070652.1) |
|||
Recombinant Mouse CD147 Protein (aa 1-209) [Fc] |
|||
| VAng-Cr3911-50g | Creative Biolabs | 50 µg | 1232.4 EUR |
|
Description: Recombinant Mouse CD147 Protein (Met 1-Arg 209) fused with a Fc tag at C-terminus was expressed in HEK293 Cells, with a molecular weight of 48.6 kDa. (Accession ID: NP_001070652.1) |
|||
Recombinant Mouse CD147 Protein (aa 1-209) [His] |
|||
| VAng-Cr3913-100g | Creative Biolabs | 100 µg | 2024.4 EUR |
|
Description: Recombinant Mouse CD147 Protein (Met 1-Arg 209) fused with a His tag at C-terminus was expressed in HEK293 Cells, with a molecular weight of 30 kDa. (Accession ID: NP_001070652.1) |
|||
Recombinant Mouse CD147 Protein (aa 1-209) [His] |
|||
| VAng-Cr3913-50g | Creative Biolabs | 50 µg | 1232.4 EUR |
|
Description: Recombinant Mouse CD147 Protein (Met 1-Arg 209) fused with a His tag at C-terminus was expressed in HEK293 Cells, with a molecular weight of 30 kDa. (Accession ID: NP_001070652.1) |
|||
Anti-Hu CD147 Purified Low Endotoxin |
|||
| 12-507-C100 | ExBio | 0.1 mg | 200.4 EUR |
CD147 antibody (PE) |
|||
| 61R-1311 | Fitzgerald | 50 ug | 249.6 EUR |
|
Description: Rat monoclonal CD147 antibody (PE) |
|||
CD147 antibody (PE) |
|||
| 61R-CD147aHUPE | Fitzgerald | 120 tests | 703.2 EUR |
|
Description: Mouse monoclonal CD147 antibody (PE) |
|||
CD147(8D6) Antibody |
|||
| BNCA0424-250 | Biotium | 250uL | 459.6 EUR |
|
Description: Primary antibody against CD147(8D6), APC conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC800424-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CD147(8D6), CF680 conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC800424-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CD147(8D6), CF680 conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC810424-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CD147(8D6), CF680R conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC810424-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CD147(8D6), CF680R conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC940424-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CD147(8D6), CF594 conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC940424-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CD147(8D6), CF594 conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC700424-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CD147(8D6), CF770 conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC700424-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CD147(8D6), CF770 conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC880424-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CD147(8D6), CF488A conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC880424-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CD147(8D6), CF488A conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC400424-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CD147(8D6), CF640R conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC400424-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CD147(8D6), CF640R conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC050424-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CD147(8D6), CF405M conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC050424-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CD147(8D6), CF405M conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNCB0424-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CD147(8D6), Biotin conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNCB0424-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CD147(8D6), Biotin conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNCAP0424-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CD147(8D6), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNCAP0424-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CD147(8D6), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNCR0424-250 | Biotium | 250uL | 459.6 EUR |
|
Description: Primary antibody against CD147(8D6), RPE conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNCP0424-250 | Biotium | 250uL | 459.6 EUR |
|
Description: Primary antibody against CD147(8D6), PerCP conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNUM0424-50 | Biotium | 50uL | 474 EUR |
|
Description: Primary antibody against CD147(8D6), 1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNCH0424-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CD147(8D6), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNCH0424-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CD147(8D6), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNUB0424-100 | Biotium | 100uL | 250.8 EUR |
|
Description: Primary antibody against CD147(8D6), Concentration: 0.2mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNUB0424-500 | Biotium | 500uL | 549.6 EUR |
|
Description: Primary antibody against CD147(8D6), Concentration: 0.2mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC040424-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CD147(8D6), CF405S conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC040424-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CD147(8D6), CF405S conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC550424-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CD147(8D6), CF555 conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC550424-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CD147(8D6), CF555 conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC610424-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CD147(8D6), CF660R conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC610424-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CD147(8D6), CF660R conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC680424-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CD147(8D6), CF568 conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC680424-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CD147(8D6), CF568 conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC470424-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CD147(8D6), CF647 conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC470424-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CD147(8D6), CF647 conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC430424-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CD147(8D6), CF543 conjugate, Concentration: 0.1mg/mL |
|||
CD147(8D6) Antibody |
|||
| BNC430424-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CD147(8D6), CF543 conjugate, Concentration: 0.1mg/mL |
|||
CD147 Antibody (FITC) |
|||
| abx139075-100tests | Abbexa | 100 tests | 510 EUR |
CD147 Antibody (FITC) |
|||
| abx200502-100tests | Abbexa | 100 tests | 477.6 EUR |
CD147 Antibody (FITC) |
|||
| abx133900-100Assays | Abbexa | 100 Assays | 526.8 EUR |
CD147 Antibody (FITC) |
|||
| abx133900-50Assays | Abbexa | 50 Assays | 410.4 EUR |
CD147(CB43) Antibody |
|||
| BNCA0363-250 | Biotium | 250uL | 459.6 EUR |
|
Description: Primary antibody against CD147(CB43), APC conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC800363-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CD147(CB43), CF680 conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC800363-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CD147(CB43), CF680 conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC810363-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CD147(CB43), CF680R conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC810363-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CD147(CB43), CF680R conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC940363-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CD147(CB43), CF594 conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC940363-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CD147(CB43), CF594 conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC700363-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CD147(CB43), CF770 conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC700363-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CD147(CB43), CF770 conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC430363-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CD147(CB43), CF543 conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC430363-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CD147(CB43), CF543 conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC400363-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CD147(CB43), CF640R conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC400363-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CD147(CB43), CF640R conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC050363-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CD147(CB43), CF405M conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC050363-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CD147(CB43), CF405M conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNCB0363-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CD147(CB43), Biotin conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNCB0363-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CD147(CB43), Biotin conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNCAP0363-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CD147(CB43), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNCAP0363-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CD147(CB43), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC880363-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CD147(CB43), CF488A conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC880363-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CD147(CB43), CF488A conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNCR0363-250 | Biotium | 250uL | 459.6 EUR |
|
Description: Primary antibody against CD147(CB43), RPE conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNCP0363-250 | Biotium | 250uL | 459.6 EUR |
|
Description: Primary antibody against CD147(CB43), PerCP conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNUM0363-50 | Biotium | 50uL | 474 EUR |
|
Description: Primary antibody against CD147(CB43), 1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNCH0363-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CD147(CB43), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNCH0363-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CD147(CB43), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNUB0363-100 | Biotium | 100uL | 250.8 EUR |
|
Description: Primary antibody against CD147(CB43), Concentration: 0.2mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNUB0363-500 | Biotium | 500uL | 549.6 EUR |
|
Description: Primary antibody against CD147(CB43), Concentration: 0.2mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC040363-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CD147(CB43), CF405S conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC040363-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CD147(CB43), CF405S conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC550363-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CD147(CB43), CF555 conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC550363-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CD147(CB43), CF555 conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC610363-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CD147(CB43), CF660R conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC610363-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CD147(CB43), CF660R conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC680363-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CD147(CB43), CF568 conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC680363-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CD147(CB43), CF568 conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC470363-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CD147(CB43), CF647 conjugate, Concentration: 0.1mg/mL |
|||
CD147(CB43) Antibody |
|||
| BNC470363-500 | Biotium | 500uL | 652.8 EUR |
|
Description: Primary antibody against CD147(CB43), CF647 conjugate, Concentration: 0.1mg/mL |
|||
CD147 Antibody (Biotin) |
|||
| abx139074-01mg | Abbexa | 0.1 mg | 510 EUR |
CD147 Antibody (Biotin) |
|||
| abx021360-100ug | Abbexa | 100 ug | 661.2 EUR |
CD147 antibody (biotin) |
|||
| 61R-CD147aHUBT | Fitzgerald | 100 ug | 495.6 EUR |
|
Description: Mouse monoclonal CD147 antibody (biotin) |
|||
Basigin (CD147) Antibody |
|||
| abx139069-01mg | Abbexa | 0.1 mg | 444 EUR |
Basigin (CD147) Antibody |
|||
| abx139070-01mg | Abbexa | 0.1 mg | 444 EUR |
Basigin (CD147) Antibody |
|||
| abx139071-01mg | Abbexa | 0.1 mg | 444 EUR |
Basigin (CD147) Antibody |
|||
| abx200501-100ug | Abbexa | 100 ug | 393.6 EUR |
Basigin (CD147) Antibody |
|||
| abx231430-100ug | Abbexa | 100 ug | 577.2 EUR |
Basigin (CD147) Antibody |
|||
| 20-abx133774 | Abbexa |
|
|
Basigin (CD147) Antibody |
|||
| 20-abx133902 | Abbexa |
|
|
Basigin (CD147) Antibody |
|||
| abx021361-02mg | Abbexa | 0.2 mg | 1312.8 EUR |
Basigin (CD147) Antibody |
|||
| abx019020-100ug | Abbexa | 100 ug | 410.4 EUR |
Basigin (CD147) Antibody |
|||
| abx413466-02mg | Abbexa | 0.2 mg | 678 EUR |
Basigin (CD147) Antibody |
|||
| abx413470-1mg | Abbexa | 1 mg | 994.8 EUR |
Basigin (CD147) Antibody |
|||
| abx413959-025mg | Abbexa | 0.25 mg | 678 EUR |
Basigin (CD147) Antibody |
|||
| abx413960-01mg | Abbexa | 0.1 mg | 526.8 EUR |
Basigin (CD147) Antibody |
|||
| abx415446-2ml | Abbexa | 2 ml | 727.2 EUR |
Basigin (CD147) Antibody |
|||
| abx414662-01mg | Abbexa | 0.1 mg | 910.8 EUR |
Basigin (CD147) Antibody |
|||
| 20-abx007567 | Abbexa |
|
|
Basigin (CD147) Antibody |
|||
| 20-abx013476 | Abbexa |
|
|
CD147 Conjugated Antibody |
|||
| C49372 | SAB | 100ul | 476.4 EUR |
Rat Monoclonal Anti-Mouse CD147, PE (Clone OX114) (rat IgG1) |
|||
| MCD147-PE | Alpha Diagnostics | 50 tests | 416.4 EUR |
Rat Monoclonal Anti-Mouse CD147, FITC (Clone OX114) (rat IgG1) |
|||
| MCD147-F | Alpha Diagnostics | 50 Tests | 489.6 EUR |
Rat Monoclonal Anti-Mouse CD147, Biotin (Clone OX114) (rat IgG1) |
|||
| MCD147-B | Alpha Diagnostics | 100 tests | 562.8 EUR |
Rat Monoclonal Anti-Mouse CD147, Purified (Clone OX114) (rat IgG1) |
|||
| MCD147-M | Alpha Diagnostics | 100 ug | 578.4 EUR |
Mouse Extracellular matrix metalloproteinase lnducer/CD147 ELISA kit |
|||
| E03E0036-192T | BlueGene | 192 tests | 1524 EUR |
|
Description: A competitive ELISA for quantitative measurement of Mouse Extracellular matrix metalloproteinase lnducer/CD147 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Mouse Extracellular matrix metalloproteinase lnducer/CD147 ELISA kit |
|||
| E03E0036-48 | BlueGene | 1 plate of 48 wells | 624 EUR |
|
Description: A competitive ELISA for quantitative measurement of Mouse Extracellular matrix metalloproteinase lnducer/CD147 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
Mouse Extracellular matrix metalloproteinase lnducer/CD147 ELISA kit |
|||
| E03E0036-96 | BlueGene | 1 plate of 96 wells | 822 EUR |
|
Description: A competitive ELISA for quantitative measurement of Mouse Extracellular matrix metalloproteinase lnducer/CD147 in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
|||
PE Anti-human CD147 Antibody *MEM-M6/6* |
|||
| 114701K0 | AAT Bioquest | 25 tests | 383 EUR |
|
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
|||
PE Anti-human CD147 Antibody *MEM-M6/6* |
|||
| 114701K1 | AAT Bioquest | 100 tests | 995 EUR |
|
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
|||
PE Anti-human CD147 Antibody *MEM-M6/6* |
|||
| 114701K2 | AAT Bioquest | 500 tests | 2984 EUR |
|
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
|||
PE Anti-human CD147 Antibody *MEM-M6/6* |
|||
| 114701K0-25tests | AAT Bioquest | 25 tests | 383 EUR |
|
Description: The MEM-M6/6 monoclonal antibody binds to human CD147, a 55 - 65 kD member of the Ig superfamily often expressed on the surface of endothelial cells and leukocytes. |
|||
PE Anti-human CD147 Antibody *MEM-M6/6* |
|||
| 114701K1-100tests | AAT Bioquest | 100 tests | 995 EUR |
|
Description: The MEM-M6/6 monoclonal antibody binds to human CD147, a 55 - 65 kD member of the Ig superfamily often expressed on the surface of endothelial cells and leukocytes. |
|||
PE Anti-human CD147 Antibody *MEM-M6/6* |
|||
| 114701K2-500tests | AAT Bioquest | 500 tests | 2984 EUR |
|
Description: The MEM-M6/6 monoclonal antibody binds to human CD147, a 55 - 65 kD member of the Ig superfamily often expressed on the surface of endothelial cells and leukocytes. |
|||
APC Anti-human CD147 Antibody *MEM-M6/6* |
|||
| 114701B0 | AAT Bioquest | 25 tests | 383 EUR |
|
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
|||
APC Anti-human CD147 Antibody *MEM-M6/6* |
|||
| 114701B1 | AAT Bioquest | 100 tests | 995 EUR |
|
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
|||
APC Anti-human CD147 Antibody *MEM-M6/6* |
|||
| 114701B2 | AAT Bioquest | 500 tests | 2984 EUR |
|
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
|||
APC Anti-human CD147 Antibody *MEM-M6/6* |
|||
| 114701B0-25tests | AAT Bioquest | 25 tests | 383 EUR |
|
Description: The MEM-M6/6 monoclonal antibody binds to human CD147, a 55 - 65 kD member of the Ig superfamily often expressed on the surface of endothelial cells and leukocytes. |
|||
APC Anti-human CD147 Antibody *MEM-M6/6* |
|||
| 114701B1-100tests | AAT Bioquest | 100 tests | 995 EUR |
|
Description: The MEM-M6/6 monoclonal antibody binds to human CD147, a 55 - 65 kD member of the Ig superfamily often expressed on the surface of endothelial cells and leukocytes. |
|||
APC Anti-human CD147 Antibody *MEM-M6/6* |
|||
| 114701B2-500tests | AAT Bioquest | 500 tests | 2984 EUR |
|
Description: The MEM-M6/6 monoclonal antibody binds to human CD147, a 55 - 65 kD member of the Ig superfamily often expressed on the surface of endothelial cells and leukocytes. |
|||
FITC Anti-human CD147 Antibody *MEM-M6/6* |
|||
| 114701G0 | AAT Bioquest | 100 tests | 547 EUR |
|
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
|||
FITC Anti-human CD147 Antibody *MEM-M6/6* |
|||
| 114701G1 | AAT Bioquest | 500 tests | 2051 EUR |
|
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
|||
FITC Anti-human CD147 Antibody *MEM-M6/6* |
|||
| 114701G0-100tests | AAT Bioquest | 100 tests | 547 EUR |
|
Description: The MEM-M6/6 monoclonal antibody binds to human CD147, a 55 - 65 kD member of the Ig superfamily often expressed on the surface of endothelial cells and leukocytes. |
|||
FITC Anti-human CD147 Antibody *MEM-M6/6* |
|||
| 114701G1-500tests | AAT Bioquest | 500 tests | 2051 EUR |
|
Description: The MEM-M6/6 monoclonal antibody binds to human CD147, a 55 - 65 kD member of the Ig superfamily often expressed on the surface of endothelial cells and leukocytes. |
|||
TRITC Anti-human CD147 Antibody *MEM-M6/6* |
|||
| 114701H0 | AAT Bioquest | 100 tests | 547 EUR |
|
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
|||
TRITC Anti-human CD147 Antibody *MEM-M6/6* |
|||
| 114701H1 | AAT Bioquest | 500 tests | 2051 EUR |
|
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
|||
PerCP Anti-human CD147 Antibody *MEM-M6/6* |
|||
| 114701S0 | AAT Bioquest | 25 tests | 383 EUR |
|
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
|||
PerCP Anti-human CD147 Antibody *MEM-M6/6* |
|||
| 114701S1 | AAT Bioquest | 100 tests | 995 EUR |
|
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
|||
PerCP Anti-human CD147 Antibody *MEM-M6/6* |
|||
| 114701S2 | AAT Bioquest | 500 tests | 2984 EUR |
|
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
|||
TRITC Anti-human CD147 Antibody *MEM-M6/6* |
|||
| 114701H0-100tests | AAT Bioquest | 100 tests | 547 EUR |
|
Description: The MEM-M6/6 monoclonal antibody binds to human CD147, a 55 - 65 kD member of the Ig superfamily often expressed on the surface of endothelial cells and leukocytes. |
|||
TRITC Anti-human CD147 Antibody *MEM-M6/6* |
|||
| 114701H1-500tests | AAT Bioquest | 500 tests | 2051 EUR |
|
Description: The MEM-M6/6 monoclonal antibody binds to human CD147, a 55 - 65 kD member of the Ig superfamily often expressed on the surface of endothelial cells and leukocytes. |
|||
PerCP Anti-human CD147 Antibody *MEM-M6/6* |
|||
| 114701S0-25tests | AAT Bioquest | 25 tests | 383 EUR |
|
Description: The MEM-M6/6 monoclonal antibody binds to human CD147, a 55 - 65 kD member of the Ig superfamily often expressed on the surface of endothelial cells and leukocytes. |
|||
PerCP Anti-human CD147 Antibody *MEM-M6/6* |
|||
| 114701S1-100tests | AAT Bioquest | 100 tests | 995 EUR |
|
Description: The MEM-M6/6 monoclonal antibody binds to human CD147, a 55 - 65 kD member of the Ig superfamily often expressed on the surface of endothelial cells and leukocytes. |
|||
PerCP Anti-human CD147 Antibody *MEM-M6/6* |
|||
| 114701S2-500tests | AAT Bioquest | 500 tests | 2984 EUR |
|
Description: The MEM-M6/6 monoclonal antibody binds to human CD147, a 55 - 65 kD member of the Ig superfamily often expressed on the surface of endothelial cells and leukocytes. |
|||
PacBlue Anti-human CD147 Antibody *MEM-M6/6* |
|||
| 114701I0 | AAT Bioquest | 100 tests | 547 EUR |
|
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
|||
PacBlue Anti-human CD147 Antibody *MEM-M6/6* |
|||
| 114701I1 | AAT Bioquest | 500 tests | 2051 EUR |
|
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
|||
PacBlue Anti-human CD147 Antibody *MEM-M6/6* |
|||
| 114701I0-100tests | AAT Bioquest | 100 tests | 547 EUR |
|
Description: The MEM-M6/6 monoclonal antibody binds to human CD147, a 55 - 65 kD member of the Ig superfamily often expressed on the surface of endothelial cells and leukocytes. |
|||
PacBlue Anti-human CD147 Antibody *MEM-M6/6* |
|||
| 114701I1-500tests | AAT Bioquest | 500 tests | 2051 EUR |
|
Description: The MEM-M6/6 monoclonal antibody binds to human CD147, a 55 - 65 kD member of the Ig superfamily often expressed on the surface of endothelial cells and leukocytes. |
|||
Purified Anti-human CD147 Antibody *MEM-M6/6* |
|||
| 11470000 | AAT Bioquest | 100 ug | 365 EUR |
|
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
|||
Purified Anti-human CD147 Antibody *MEM-M6/6* |
|||
| 11470000-100ug | AAT Bioquest | 100 ug | 365 EUR |
|
Description: The MEM-M6/6 monoclonal antibody binds to human CD147, a 55 - 65 kD member of the Ig superfamily often expressed on the surface of endothelial cells and leukocytes. |
|||
PacOrange Anti-human CD147 Antibody *MEM-M6/6* |
|||
| 114701J0 | AAT Bioquest | 100 tests | 547 EUR |
|
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
|||
PacOrange Anti-human CD147 Antibody *MEM-M6/6* |
|||
| 114701J1 | AAT Bioquest | 500 tests | 2051 EUR |
|
Description: R-Phrase for Dangerous Goods accord. to EU 67/548 EWG: R20, R21, R22; H-Phrases (GHS) for Dangerous Goods accord. to 1272/2008: H303, H313, H333; Symbol for Dangerous Compound accord. to EU 67/548 EWG: Xn |
|||
PacOrange Anti-human CD147 Antibody *MEM-M6/6* |
|||
| 114701J0-100tests | AAT Bioquest | 100 tests | 547 EUR |
|
Description: The MEM-M6/6 monoclonal antibody binds to human CD147, a 55 - 65 kD member of the Ig superfamily often expressed on the surface of endothelial cells and leukocytes. |
|||
PacOrange Anti-human CD147 Antibody *MEM-M6/6* |
|||
| 114701J1-500tests | AAT Bioquest | 500 tests | 2051 EUR |
|
Description: The MEM-M6/6 monoclonal antibody binds to human CD147, a 55 - 65 kD member of the Ig superfamily often expressed on the surface of endothelial cells and leukocytes. |
|||
CD147(BSG/963) Antibody |
|||
| BNC800963-100 | Biotium | 100uL | 238.8 EUR |
|
Description: Primary antibody against CD147(BSG/963), CF680 conjugate, Concentration: 0.1mg/mL |
|||
Susceptibility testing and molecular analyses revealed lowering GAS macrolide resistance charges, which can be attributed to the discount within the consumption of macrolides and/or the diminished circulation of macrolide-resistant clones lately. Such knowledge might present beneficial baseline data in focusing on therapeutic intervention and the formulation of type-specific GAS vaccines.